GlassScriptPhysician profile
Susan M Palleschi
NPI 1437234572
$2,753.50
in general payments reported to CMS, 2019-2025
9 companies · $684 in 2025
The $684 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $16.31 · 2021: $182 · 2022: $69.34 · 2023: $1,400 · 2024: $402 · 2025: $684.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,799 · Travel and Lodging: $687.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,799.19 |
| Travel and Lodging | $686.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axogen | $1,439.14 | 2022-2024 | Axoguard Nerve Protector, Axoguard Nerve Connector, Avance Nerve Graft |
| Dilon Technologies, INC. | $648.76 | 2024-2025 | Hemoblast Bellows |
| Endomagnetics LTD | $349.04 | 2021-2023 | Magseed, Magtrace |
| W. L. Gore & Associates, INC. | $200.65 | 2025 | Gore Synecor Biomaterial |
| Tactile Systems Technology INC | $44.23 | 2019-2022 | |
| Genzyme Corporation | $27.51 | 2021 | |
| Myriad Genetic Laboratories, INC. | $24.52 | 2024 | Myrisk |
| Hologic INC | $13.15 | 2022 | |
| Kub Technologies INC. | $6.50 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Susan Palleschi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.